Derivative Financial Instruments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Derivative Financial Instruments (Details) [Line Items]
Expire date	Sep. 24, 2026
Non voting common stock (in Shares)	91,102
Warrants outstanding (in Shares)	499,986
Fair value equity	$ 700,000
Recognized gain (loss)	$ 600,000	$ 7,200,000
Fair value of common stock		$ 200,000
Outstanding common stock warrants (in Shares)	11,163,896	3,804,427
Common stock warrants outstading		$ 150,000
Estimated fair value	100,000	100,000
Fair value of earnout liability	(18,000)	$ (5,725,000)
Common Stock [Member]
Derivative Financial Instruments (Details) [Line Items]
Outstanding common stock warrants (in Shares)		4,999,863
Common stock warrants outstading	499,986
Monte Carlo valuation model [Member]
Derivative Financial Instruments (Details) [Line Items]
Fair value of earnout liability	$ 100,000
Business Combination [Member]
Derivative Financial Instruments (Details) [Line Items]
Description of contingent earnout liability	Upon the closing of the business combination and pursuant to the Sponsor Support Agreement, the Sponsor agreed to place the 105,000 Earnout Shares into escrow, which will be released as follows: (a) 25,000 Earnout Shares will be released if, during the period from and after September 24, 2021 until September 24, 2024 (the “Earnout Period”), over any twenty trading days within any thirty day consecutive trading day period, the volume-weighted average price of the Company’s common stock (the “Applicable VWAP”) is greater than or equal to $115.00, (b) 50,000 Earnout Shares will be released if, during the Earnout Period, the Applicable VWAP is greater than or equal to $150.00 and (c) 30,000 Earnout Shares will be released if, during the Earnout Period, the Applicable VWAP is greater than or equal to $180.00 (the “triggering events”).